387570.KQ Finemedix Co., Ltd.
- Market cap
- KRW 30.7B
- P/E
- -
- P/B
- 1.61x
- ROE
- 0.3%
- Dividend yield
- -
- Fundamental score
- 1.6/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 387570.KQ undervalued?
Graham numberThe Graham number of Finemedix Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Finemedix Co., Ltd. fundamental analysis
8 of 22 checks passedROE 0/2
Low return on equity (0.3%), below 10%.
ROA 1/1
Return on assets (0.2%) is above the industry median (-9.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-7,675.3%) is below the industry median (-3.8%).
Revenue Growth 1/2
Revenue grew 5.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (8.5%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
No interest expense reported.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (1.6x) is below the industry median (3.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Finemedix Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Finemedix Co., Ltd.
Finemedix Co., Ltd. manufactures and sells medical devices in South Korea. It offers knives; polypectomy and EMR snares and retrieval nets; hemostatic forceps, injection catheters, hemoclips, coagulation probes, and clearcoajets; and biopsy products, such as disposable, disposable, reusable, and hot biopsy forceps. The company also provides EUS/EBUS products; ERCP baskets and cannulas, and sphincterotomes; and accessories, including distal caps, mouth pieces, and other produ…
Full company profileFinemedix Co., Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Finemedix Co., Ltd. annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 8.14B | 10.2B | 9.96B | 9.52B | 12.5B |
| Gross Profit | 4.41B | 5.64B | 5.71B | 4.60B | 6.91B |
| Operating Income | -661M | 874M | -29.2M | -2.58B | 77.9M |
| EBITDA | 1.51B | 2.34B | 906M | -1.50B | 952M |
| Net Income | 240M | 1.18B | -24.2M | -1.88B | 47.8M |
| EPS | 44 | 217 | -4.45 | -346 | 8.81 |
| Balance Sheet | |||||
| Total Assets | 18.6B | 18.5B | 26.9B | 25.5B | 24.1B |
| Total Liabilities | 7.00B | 5.90B | 6.11B | 6.52B | 5.02B |
| Shareholders' Equity | 11.6B | 12.6B | 20.8B | 19.0B | 19.1B |
| Cash & Short-term Investments | 1.18B | 1.89B | 10.4B | 3.14B | 4.07B |
| Cash Flow | |||||
| Operating Cash Flow | -1.43B | 1.38B | 171M | -2.63B | 1.34B |
| Capital Expenditure | 695M | 336M | 595M | 853M | 88.4M |
| Free Cash Flow | -2.13B | 1.04B | -425M | -3.49B | 1.25B |
| Ratios | |||||
| ROE | 2.1% | 9.3% | -0.1% | -9.9% | 0.3% |
| ROA | 1.3% | 6.3% | -0.1% | -7.4% | 0.2% |
| Net Profit Margin | 2.9% | 11.6% | -0.2% | -19.7% | 0.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Finemedix Co., Ltd. dividends
Finemedix Co., Ltd. has not paid dividends in the last 4 fiscal years.
Who owns Finemedix Co., Ltd.
- Insiders 37.12%
- Institutions 0.00%
- Public & others 62.88%
- Shares outstanding 5.43M
- Free float 3.09M
Finemedix Co., Ltd. company profile
- Company name
- Finemedix Co., Ltd.
- Ticker
- 387570.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 70
- Fiscal year end
- December
- Address
- 140-9, Yuram-ro, Dong-gu, Daegu, South Korea, 41059
- Phone
- 82 5 3741 8388
- Website
- finemedix.com
About Finemedix Co., Ltd.
Finemedix Co., Ltd. manufactures and sells medical devices in South Korea. It offers knives; polypectomy and EMR snares and retrieval nets; hemostatic forceps, injection catheters, hemoclips, coagulation probes, and clearcoajets; and biopsy products, such as disposable, disposable, reusable, and hot biopsy forceps. The company also provides EUS/EBUS products; ERCP baskets and cannulas, and sphincterotomes; and accessories, including distal caps, mouth pieces, and other products. The company was founded in 2009 and is based in Daegu, South Korea.
Finemedix Co., Ltd. management
3- Mr. Seong-Woo JeonCEO & Representative Director · born 1971
- Mr. Joongbo HwangExecutive Director of Sales Department & Director · born 1980
- Mr. Seong-Cheol KimVP & Representative Director · born 1976